Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Year-End Report

with quarterly report for the period 1 October 2019 to 31 December 2019 Full year 2019 in summary · Net sales amounted to 151,645 kSEK · Adjusted EBITDA amounted to 22,960 kSEK excluding non-recurring items of 19,862 kSEK · EBITDA amounted to 3,098 kSEK · Cash balance amounted to 105,740 kSEK · Net debt amounted to 126,372 kSEK · Equity amounted to 250,126 kSEK · Earnings per share amounted to -0,0009 SEK Fourth quarter in summary · Sales amounted to 56,740 (66,460) kSEK · Adjusted EBITDA amounted to 4,613 kSEK, excluding non-recurring items of 22,000

Polygiene AB (publ.) Interim Report October 1–December 31 2019

Growth, continuous strong gross margin and improved cashflow compared to last year.Q4 in brief · Net sales increased by 2.1 % during the fourth quarter compared to the same period last year and amounted to MSEK 19.0 (18.6). Adjusted from the divestment of Protective surfaces, the corresponding figure is 6.7 %. · The operating profit/loss before tax for the period ended at MSEK -2.2 (0.5). The result is affected by MSEK 1.2 in extraordinary costs. · The gross margin is continuous strong and amounted to 68.6 (63.3) % for the period. · Cash flow of the fourth quarter improved

ContextVision Grows Medical Imaging Market Footprint With New Global Customers

STOCKHOLM – February 27, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announced new growth within its market-leading medical image processing business. Newly signed customer contracts in both Asia and the United States are driving increased revenue in Q1 2020 and beyond. ContextVision continues to set the highest global industry standards across various imaging modalities. The company’s important value proposition for its image enhancement products and services is further validated by these new contracts and

Redeye: Gaming Innovation Group - All-in on B2B

Redeye cuts the valuation of GiG as a consequence of its B2C divestment. While the Q4’19 report otherwise was uneventful, the strategic move is significant. On a positive note, financial gearing is coming down and the remaining B2B business is developing well. We view the selling price as clearly low, however, and the future potential is reduced due to this effective halving of GiG’s business. On balance, we still see substantial upside in the stock from currently depressed levels. Read more and download the research update: http://bit.ly/GIG-B2B Start following companies at Redeye to

Quarterly Report October To December 2019

Growth Plan Secured By Fully Subscribed Rights IssueJANUARY TO DECEMBER 2019 · Order Intake was 62.7 MSEK (55.4) and Order Backlog increased to 49.9 MSEK (35.2) · Net Sales totalled 49.1 MSEK (44.9) · Gross Margin increased to 61% (45) · Usage Revenue increased to 16% (12) · Adjusted EBITDA was -112.8 MSEK (-100.3) · Non-recurring expenses in connection with the reverse takeover in February totalling -28.5 MSEK · Earnings per share -7.40 SEK OCTOBER TO DECEMBER 2019 · Order Intake was 17.0 MSEK (23.8) and Order Backlog increased to 49.9 MSEK (35.2) · Net

Kongsberg Automotive reports Q4 2019 results

Kongsberg Automotive ASA Q4 2019 Report and Presentation follow attached. Q4 2019 Highlights: · Revenues declined by MEUR 7.5 (-2.6%) YoY to MEUR 280.8. This includes positive FX effects of MEUR 1.8. On a fixed exchange rate basis, our revenues declined by 3.2% YoY. · In Q4 we experienced strongly declining revenues in November and December to a greater degree than the decline in our customers’ production rates. · We continued to gain market share in the passenger car market, mainly driven by strong P&C growth in China. Overall, on a constant currency basis we had virtually

Increased sales for PowerCell full year 2019

PowerCell Sweden AB increased its sales for the full year 2019 with 10 percent, up from MSEK 60.5 to MSEK 66.8 compared to the full year 2018. Sales during the fourth quarter noted a slight decrease, down from MSEK 28.1 to MSEK 27 compared to the same period last year. Operating income for the fourth quarter amounted to MSEK -28,8 compared to MSEK -11.1 the same period last year.“The reason for the decrease in sales during the quarter is lower sales of PowerCell S3 to the automotive segment following our agreement with Bosch. The weaker operating income is due to vigorous efforts within

Skanska builds new hospital building in Oulu, Finland, for EUR 190 M, about SEK 2.0 billion

Skanska has signed a contract with Oulu University Hospital to build a new hospital building in Oulu, Finland. Skanska’s share of the contract is worth EUR 190 M, about SEK 2.0 billion, which will be included in the Nordic order bookings for the first quarter of 2020.The new ten-story main building, with a total area of about 59,000 square meters, will house functions for emergency rooms, intensive care units, operating rooms, delivery wards and support functions. The new building will replace outdated hospital buildings completed in the 1970’s. The building consists of two parts built

Caverion and its alliance partners to implement a new hospital in Oulu, Finland - One of the biggest projects for Caverion

Caverion Corporation 27 February 2020 at 8.30 a.m. EETCaverion and its alliance partners to implement a new hospital in Oulu, Finland - One of the biggest projects for Caverion Caverion and its alliance partners have signed a contract with Northern Ostrobothnia Hospital District to implement the so-called B-part for a new building of the university hospital in Oulu. Caverion will be responsible for the B-hospital’s technical solutions, safety and communications technology and design management. The value of the contract for Caverion is over EUR 100 million. The project is

SDRL - Seadrill Limited Announces Fourth Quarter 2019 Results

Highlights · Revenue up 8% at $398 million with higher proportion of reimbursable revenues · Technical utilization of 97% and economic utilization of 93%  · Operating Loss of $93 million · Adjusted EBITDA of $39 million, in line with guidance of $40 million  · Net loss of $199 million equivalent to net loss per share of $1.99 · Strong order intake of $1.0 billion, resulting in total backlog of $2.5 billion at year end.  · Closing cash of $1.4 billion Subsequent Events · Continued productive discussions with banking group regarding capital structure. ·

SDRL – Change to Board of Directors

Hamilton, Bermuda, February 27, 2020 - Seadrill Limited ("Seadrill" or the "Company") is pleased to announce that Birgit Aagaard-Svendsen and Herman R. Flinder will be joining the board from February 27, 2020, replacing Eugene I. Davis and Scott D. Vogel who have taken the decision to step down from their current positions.  Ms. Aagaard-Svendsen brings with her extensive of experience serving on boards and as audit committee chair of public companies. Her previous experience includes serving as chief financial officer in the shipping company J. Lauritzen A/S for 18 years and as a member

Nel ASA: Received purchase order for a 1 MW containerized PEM electrolyzer in the US

(Oslo, 27 February 2020) Nel Hydrogen US, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a purchase order for a 1 megawatt containerized Proton PEM® electrolyzer from Trillium Transportation Fuels, LLC (Trillium). The electrolyser will be used to produce hydrogen for a fleet of fuel cell electric buses in Urbana, Illinois, USA. “We’re proud to have received a purchase order for a megawatt scale containerized Proton PEM® electrolyser which will be used to produce green hydrogen for a fleet of up to 12 fuel cell electric buses at the Champaign-Urbana Mass Transit District (MTD) in

Nordic Nanovector ASA – resultat for fjerde kvartal og helår 2019

Nordic Nanovector ASA (OSE: NANO) publiserer i dag sine resultater for fjerde kvartal 2019. Selskapets ledelse vil gi en presentasjon av resultatene klokken 08:30 på Thon Hotel Vika Atrium i Oslo. Se ytterligere informasjon nedenfor. Vi har nå innrullert 47 pasienter i vår målrettede PARADIGME fase 2b studie med Betalutin®. Selskapet vil under ny ledelse se nærmere på gjeldende strategiske og operasjonelle aktiviteter. Vårt mål er fortsatt å fullføre pasientinnrulleringen til PARADIGME-studien i andre halvår 2020. De lovende resultatene fra den kliniske studien LYMRIT 37-01 fase 1/2

Höegh LNG: Key information relating to the cash dividend to be paid by Höegh LNG Holdings Ltd.

Hamilton, Bermuda, 27 February 2020 – Key information relating to the cash dividend to be paid by Höegh LNG Holdings Ltd. Dividend amount: USD 0.025 per share Declared currency: United States Dollar Last day including right: 4 March 2020 Ex-date: 5 March 2020 Record date: 6 March 2020 Payment date: On or about 19 March 2020 Date of approval: 26 February 2020  This information is published in accordance with the requirements of the Continuing Obligations.    * * *

Höegh LNG: Interim results for the quarter and year ended 31 December 2019

Hamilton, Bermuda, 27 February 2020 - Höegh LNG Holdings Ltd. ("Höegh LNG") today reports its financial results for the quarter and year ended 31 December 2019Highlights for the fourth quarter of 2019: · EBITDA of USD 59.8 million  · Net profit of USD 4.0 million  · Dividend of USD 0.025 per share paid in the fourth quarter of 2019   Subsequent events: · Dividend of USD 0.025 per share declared for the first quarter of 2020  · Secured a revolving credit facility of USD 80 million and a new bond loan of NOK 650 million to refinance the HLNG 02 bond maturing in June

Solteq Plc’s Financial Statements Bulletin January 1 – December 31, 2019

Solteq Plc Stock Exchange Bulletin February 27, 2020 at 8.00 am 2019 – a year of international business growth and innovation  October–December•    Revenue totaled 15,708 thousand euros (14,930).•    EBITDA was 4,387 thousand euros (1,146).•    Operating profit was 3,328 thousand euros (645).•    The SAP ERP business was transferred to Enfo Oyj on January 1, 2020. The capital gain from the divestment improved the Group's EBITDA and operating profit by 2,515 thousand euros.•    The implementation of IFRS 16 standard improved EBITDA by 490 thousand euros and the operating

Photocure ASA: Results for the fourth quarter of 2019

Oslo, Norway, 27 February 2020: Photocure ASA (OSE:PHO), today reported a revenue growth of 51% for the U.S. market in the fourth quarter of 2019, contributing to Hexvix/Cysview revenues of NOK 58.8 million (Q4 2018: NOK 46.3) and a recurring EBITDA of NOK 1.6 million (NOK 1.3 million).Based on the outlook and strategic opportunities, Photocure targets U.S. revenues in the range of USD 70 million in 2023, and sees significant continued revenue growth and profit opportunities in the U.S. market beyond 2023 “Photocure continued its strong U.S. sales momentum and solid growth in the fourth

Nordic Nanovector ASA - Results for the Fourth Quarter and Full Year 2019

Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth quarter and full year 2019. A presentation by the company’s senior management team will take place today in Oslo at 08:30 CET, see details below. Jan H. Egberts, MD, Chairman of Nordic Nanovector, commented: “We currently have 47 patients enrolled in our pivotal PARADIGME Phase 2b trial evaluating Betalutin®. The company will under its new management look into the current strategy and operational trial initiatives. We still aim to complete the patient enrolment in PARADIGME in the second half of 2020. The encouraging

Otello Corporation announces fourth quarter results

Oslo, Norway - February 27, 2020 - Otello Corporation today reported financial results for the fourth quarter, which ended December 31, 2019. Please find the fourth quarter report (4Q19.pdf) and fourth quarter presentation (4Q19_presentation.pdf) attached. Webcast: https://www.otellocorp.com/ir Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their

Primary Insider Disclosure

The following primary insiders (or their related parties as described below) have, as part of the company's incentive program, committed to acquire shares in Ocean Yield ASA (the "Company" or "Ocean Yield"): · Andreas Røde, Head of Business Development and M&A, has through his wholly owned company Vulpes Holding AS acquired 10,000 shares in Ocean Yield. Upon completion of such acquisition, Andreas Røde will own, directly or indirectly, 55,000 shares in the Company. · Andreas Reklev, SVP Investments, has through his wholly owned company Reklev Invest AS acquired 10,000 shares in

Repurchase of own shares

TietoEVRY Corporation           Stock Exchange Announcement         26 February 2020 6.35 pm EET Date: 26 February 2020 Exchange transaction: Buy Share class: TIETO Amount, shares: 35 000 Average price/share, EUR 25.5477 Total price, EUR 894 169.50                          The number of shares held by TietoEVRY Corporation after the completion of transactions: 207 245 shares.                         On behalf of TietoEVRY Corporation                                       EVLI BANK PLC                        Lauri Vehkaluoto     Further Enquiries:

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 26.02.2020

Fiskars Corporation NOTIFICATION   26.02.2020 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 26.02.2020   Date 26.02.2020  Exchange transaction Buy  Share class FSKRS  Amount       1,000  Average price/share 11.2825 EURHighest price/share 11.3200 EURLowest price/share 11.2200 EURTotal price 11,282.50 EUR        The shares held by Fiskars Corporation on 26.02.2020:     FSKRS  425,677       On behalf

ADDvise receives allocation decision worth approximately MSEK 2.2 – Regulatory information

ADDvise Group AB (publ) subsidiary Sonar Oy has received an allocation decision from Kangasala town in Finland worth approximately MSEK 2.2. The allocation decision consists of an order, and with the possibility for a second order with the same value, regarding a digital radiography (DR) system used for image capturing. The decision is subject to an appeal time expiring 11 March 2020. ADDvise Group AB (publ) has adopted new guidelines regarding the assessment of information affecting the financial instrument and the disclosure thereof. Entailing that orders and investments within the

There are no items matching the current filter
There are no more items matching the current filter
Back to top